Regeneron (REGN) Tops Q2 EPS by $1.17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $927.89 +13.33%
Financial Fact:
Net product sales: 857.47M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Net product sales: 857.47M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q2 EPS of $9.77, $1.17 better than the analyst estimate of $8.60. Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.79 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $875 at Baird
- Regeneron Pharma (REGN) PT Raised to $1,020 at Raymond James
- Affle agrees to acquire Perion Network for ~$420 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
